https://www.mskcc.org/news/imlunestrant-stops-progression-of-er-her2-advanced-breast-cancer-resists-standard-therapy Memorial Sloan Kettering Cancer Center en Article 2026-09-18 FDA Expands Approval for Imlunestrant To Treat ER+, HER2-, ESR1-mutated Advanced Breast Cancer That Resists Standard Therapy https://www.mskcc.org/news/2026-gsk-chairmans-prize-recognizes-research-on-how-cells-sense-injury Memorial Sloan Kettering Cancer Center en Article 2026-09-17 2026 GSK Chairman’s Prize Recognizes Research on How Cells Sense Injury https://www.mskcc.org/news/testicular-cancer-myths Memorial Sloan Kettering Cancer Center en Article 2026-09-16 Testicular Cancer: Myths and Facts